MEGX
SIGMA/SML0087 - ≥95% (HPLC)
Synonym: MGEX; Monoethylglycinexylidide; N-
CAS Number: 7728-40-7
Empirical Formula (Hill Notation): C12H18N2O
Molecular Weight: 206.28
MDL Number: MFCD00098991
Linear Formula: C12H18N2O
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C12H18N2O/c1-4-13-8-11 |
| InChI key | WRMRXPASUROZGT-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CC1=C(NC(CNCC)=O)C(C)=CC= |
| solubility | H2O: 10 mg/mL, clear |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Application: | MEGX has been used in an approach to improve the yield of N-dealkylated lidocaine. |
| Biochem/physiol Actions: | Lidocaine metabolite |
| Biochem/physiol Actions: | MEGX is generated by hepatic cytochrome P-450 system upon oxidative de-ethylation. Measurement of MEGX by immunoassay contributes to liver function test. MEGX possesses antiarrhythmic action and therefore extends lidocaine effect. |
| Biochem/physiol Actions: | Monoethylglycinexylidide (MEGX) is an active metabolite of lidocaine. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


